Target
Kallikrein-7 [37-253,Y180R]
Ligand
BDBM203868
Substrate
n/a
Meas. Tech.
Human KLK7 Fluorescence-Lifetime Assay
pH
5.6±n/a
Temperature
298.15±n/a K
IC50
>1.00e+5±n/a nM
Comments
extracted
Citation
 Maibaum, JLiao, SMVulpetti, AOstermann, NRandl, SRüdisser, SLorthiois, EErbel, PKinzel, BKolb, FABarbieri, SWagner, JDurand, CFettis, KDussauge, SHughes, NDelgado, OHommel, UGould, TMac Sweeney, AGerhartz, BCumin, FFlohr, SSchubart, AJaffee, BHarrison, RRisitano, AMEder, JAnderson, K Small-molecule factor D inhibitors targeting the alternative complement pathway. Nat Chem Biol 12:1105-1110 (2016) [PubMed]  Article 
Target
Name:
Kallikrein-7 [37-253,Y180R]
Synonyms:
KLK7 | KLK7_HUMAN | Kalligrein-7 Y180R (KLK7) | PRSS6 | SCCE
Type:
Protein
Mol. Mass.:
23785.70
Organism:
Homo sapiens (Human)
Description:
P49862 (37-253 aa with Y180R mutation)
Residue:
217
Sequence:
ARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVRKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR
  
Inhibitor
Name:
BDBM203868
Synonyms:
(S)-N2-benzhydryl-N1-(1-methyl-1H-indol-3-yl)pyrrolidine-1,2-dicarboxamide (5)
Type:
Small organic molecule
Emp. Form.:
C28H28N4O2
Mol. Mass.:
452.5475
SMILES:
Cn1cc(NC(=O)N2CCC[C@H]2C(=O)NC(c2ccccc2)c2ccccc2)c2ccccc12 |r|
Structure:
Search PDB for entries with ligand similarity: